Cross Country Healthcare, Inc.
NASDAQ•CCRN
CEO: Mr. Kevin Cronin Clark
セクター: Healthcare
業種: Medical - Care Facilities
上場日: 2001-10-25
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
連絡先情報
6551 Park of Commerce Boulevard, N.W., Boca Raton, FL, 33487, United States
561-998-2232
時価総額
$269.29M
PER (TTM)
-17.1
33.5
配当利回り
--
52週高値
$18.15
52週安値
$7.43
52週レンジ
順位38Top 36.9%
4.3
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 4.3 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q3 2025 データ
売上高
$250.05M-20.65%
直近4四半期の推移
EPS
-$0.15-293.80%
直近4四半期の推移
フリーCF
$17.92M+182.43%
直近4四半期の推移
2025 Q3 決算ハイライト
主なハイライト
Q3 Revenue Decline Q3 service revenue totaled $250.1M, reflecting a 20.6% decrease compared to $315.1M last year due to volume declines.
Operational Loss Narrowed Nine months loss from operations improved 4.6% to ($12.8M) versus ($13.4M) prior period, showing cost control efforts.
Cash Position Strengthened Cash and equivalents reached $99.1M as of September 30, 2025, up $35.1M year-over-year, supporting liquidity.
Homecare Segment Growth Homecare Staffing segment revenue grew 29.1% year-over-year for the third quarter period, acting as a growth driver.
リスク要因
Aya Merger Uncertainty Closing contingent on FTC review; termination possible if extension is not agreed upon by the December 3, 2025 deadline.
Staffing Volume Decline Nurse and Allied FTEs decreased 16.8% in Q3 2025, driven by headcount reduction in travel nurse and allied assignments.
Bottom Line Deterioration Q3 net loss was ($4.8M), a significant reversal from $2.6M net income reported in the comparable third quarter of 2024.
Merger Cost Incurred $12.2M in acquisition and integration-related costs recorded for the pending Aya Merger during the nine months ended period.
見通し
Merger Extension Discussed Management actively discussing extending the Aya Merger end date beyond the current December 3, 2025 termination deadline.
Liquidity Strategy Clear Future cash needs expected to be met by existing cash on hand and revolving credit facility availability for flexibility.
ABL Facility Ready Revolving ABL facility has $121.4M availability with zero borrowings drawn as of September 30, 2025, ensuring access to capital.
Credit Risk Managed Allowance for credit losses stands at $8.8M, reflecting management's assessment of current economic conditions and aging receivables.
同業比較
売上高 (TTM)
$12.64B
AGL$5.89B
$1.13B
粗利益率 (最新四半期)
XOMA90.6%
TMCI79.1%
KIDS73.9%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| SNDA | $655.06M | -13.6 | -44.1% | 80.1% |
| SRDX | $614.51M | -34.8 | -15.6% | 19.2% |
| EHAB | $572.29M | -48.1 | -2.2% | 42.0% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-6.9%
成長鈍化
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績
深度リサーチ
次回決算:2026年3月4日
EPS:$0.03
|売上高:-
財務レポート
財務データ
ニュース
全年度
Form 10-Q - Q3 2025
会計期末: 2025年9月30日|提出日: 2025年11月12日|売上高: $250.05M-20.6%|EPS: $-0.15-293.8%予想を下回るForm 10-Q - Q2 2025
会計期末: 2025年6月30日|提出日: 2025年8月6日|売上高: $274.07M-19.3%|EPS: $-0.20-57.4%予想を下回るForm 10-Q - Q1 2025
会計期末: 2025年3月31日|提出日: 2025年5月7日|売上高: $293.41M-22.6%|EPS: $-0.02-125.4%予想を下回るForm 10-K/A - FY 2024
会計期末: 2024年12月31日|提出日: 2025年4月16日|売上高: $1.34B-33.5%|EPS: $-0.44-121.3%予想を下回るForm 10-K - FY 2024
会計期末: 2024年12月31日|提出日: 2025年3月5日|修正版データを参照Form 10-Q - Q3 2024
会計期末: 2024年9月30日|提出日: 2024年11月7日|売上高: $315.12M-28.8%|EPS: $0.08-79.1%予想を下回るForm 10-Q - Q2 2024
会計期末: 2024年6月30日|提出日: 2024年8月1日|売上高: $339.77M-37.2%|EPS: $-0.47-178.3%予想を下回るForm 10-Q - Q1 2024
会計期末: 2024年3月31日|提出日: 2024年5月2日|売上高: $379.17M-39.1%|EPS: $0.08-90.4%予想を下回る